Table 3 Primary outcome.

From: Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study

 

Overall

Score of 7-point ordinal scale on Day 1 (baseline)

2,3

4

5

Corticosteroid

Non-corticosteroid

Corticosteroid

Non-corticosteroid

Corticosteroid

Non-corticosteroid

Corticosteroid

Non-corticosteroid

(N = 118)

(N = 118)

(N = 15)

(N = 9)

(N = 53)

(N = 60)

(N = 48)

(N = 46)

Score of 7-point ordinal scale on Day 15—no. (%)

1

7 (5.9)

3 (2.5)

2 (13.3)

0

3 (5.7)

3 (5.0)

2 (4.2)

0

2

16 (13.6)

12 (10.2)

2 (13.3)

3 (33.3)

10 (18.9)

9 (15.0)

3 (6.3)

0

3

4 (3.4)

1 (0.8)

1 (6.7)

0

2 (3.8)

1 (1.7)

1 (2.1)

0

4

29 (24.6)

22 (18.6)

5 (33.3)

4 (44.4)

19 (35.8)

16 (26.7)

4 (8.3)

1 (2.2)

5

20 (16.9)

27 (22.9)

3 (20.0)

0

4 (7.5)

10 (16.7)

13 (27.1)

16 (34.8)

6

16 (13.6)

21 (17.8)

2 (13.3)

2 (22.2)

10 (18.9)

11 (18.3)

4 (8.3)

7 (15.2)

7

26 (22.0)

32 (27.1)

0

0

5 (9.4)

10 (16.7)

21 (43.8)

22 (47.8)

Odds ratio (95%CI)

0.611 (0.388–0.962)

0.953 (0.215–4.224)

0.626 (0.323–1.213)

0.589 (0.277–1.255)

p-value

0.034

0.950

0.165

0.170

  1. Because only a few patients had a baseline 7-point ordinal score of 3, the patients with a baseline score of 2 and 3 were combined for the analysis. Categorical variables were presented as numbers (%). Ordinal variables were compared between groups using a proportional odds model. A p value of < 0.05 was considered statistically significant. CI, confidence interval.